Karen Noblett
CIK 1756240 · Chief Medical Officer · last filed 2024-11-15
Karen Noblett is a Chief Medical Officer who has filed 11 SEC Form 4 insider transactions across 1 company since 2019. The most recent filing shows the insider disposed of $2.4M of AXNX on Nov 15, 2024. Across all open-market trades the lifetime net is −$7.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
11
-$7.04M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Axonics, Inc. (AXNX) Delisted | Chief Medical Officer | 0 | $70.98 | $0 | -$7.04M | 11 | 2024-11-15 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-11-15 | Axonics, Inc. (AXNX) Delisted | Disp (D) | −34,428 | -$2.44M | EDGAR |
| 2024-02-02 | Axonics, Inc. (AXNX) Delisted | Mixed | +16,212 | -$764.6K | EDGAR |
| 2024-01-10 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −15,999 | -$1.10M | EDGAR |
| 2023-12-28 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −8,000 | -$506.0K | EDGAR |
| 2023-02-02 | Axonics, Inc. (AXNX) Delisted | Mixed | +10,616 | -$283.2K | EDGAR |
| 2022-09-20 | Axonics, Inc. (AXNX) Delisted | Mixed | — | -$1.92M | EDGAR |
| 2022-09-09 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −10,454 | -$747.8K | EDGAR |
| 2022-03-22 | Axonics, Inc. (AXNX) Delisted | Sell (S) | −13,531 | -$774.4K | EDGAR |
| 2022-02-03 | Axonics, Inc. (AXNX) Delisted | Mixed | +18,131 | -$322.4K | EDGAR |
| 2019-07-25 | Axonics, Inc. (AXNX) Delisted | Exer (M) | +14,404 | $18.0K | EDGAR |